Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dai Wang

16PUBLICATIONS
29CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyPsychosocial aspects of childbirth and perinatal mental healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

Sort by Publication Date:
|Oct 10, 2023
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.

Sarah M Valencia, Eric Rochat, Melissa J Harnois

|Mar 11, 2022
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies.

Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku

|Jun 03, 2021
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial.

Leike Li, Daniel C Freed, Yaping Liu

|Mar 26, 2021
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.

Xi He, Shuo Quan, Min Xu

|Dec 30, 2020
The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms.

Annete Njue, Carolyn Coyne, Andrea V Margulis

|Dec 28, 2020
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus.

Hang Su, Xiaohua Ye, Daniel C Freed

Pageof 3

Frequent Collaborators

6 joint publications

Tong-Ming Fu

5 joint publications

Zhiqiang An

4 joint publications

Ningyan Zhang

1 joint publications

Giuseppe Ciaramella

1 joint publications

Jennifer A Jenks

1 joint publications

Cody S Nelson

1 joint publications

Matthew L Goodwin

1 joint publications

Robert F Pass

1 joint publications

Cliburn Chan

1 joint publications

Sallie R Permar

Frequent Collaborators

6 joint publications

Tong-Ming Fu

5 joint publications

Zhiqiang An

4 joint publications

Ningyan Zhang

1 joint publications

Giuseppe Ciaramella

Top Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on : Feb 06, 2018

10.5K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

3.8K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.7K
See more related videos

Top Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on : Feb 06, 2018

10.5K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

3.8K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.7K
See more related videos